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ABSTRACT 
 
Asthma is the most common chronic inflammatory disorder characterized by cough, 
wheezing and dyspnea in children. Nutrition is an important factor which influences on 
induction and exacerbation of asthma. There are controversies to use Vitamin E in asthmatic 
patients. The aim of this study was to evaluate the effect of vitamin E supplement in children 
with moderate asthma. 
This is a randomized double blind placebo-controlled trial performed on children (age 2-
17 years old) with moderate asthma (5-17 years old) from March 2010 to March 2012. Case 
group were treated with fluticasone and vitamin E (50mg/day) and control group received 
fluticasone plus placebo for 8 weeks. 
Out of 300 cases, 240 cases completed the study. Female to male ratio was 0.84. Serum 
level of Vitamin E significantly increased after treatment in intervention group. FEV1 and 
FEV1/FVC ratio was significantly improved in case group compared to the control group. 
It can be concluded that vitamin E supplement could improve clinical manifestations and 
pulmonary function test in children with moderate asthma. 
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INTRODUCTION 
 
Asthma is the most common chronic inflammatory 
disorder with an unknown etiology associated  
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with increased reactive oxygen species (ROS)  
and characterized by cough, wheezing and dyspnea  
in children.1-3 The prevalence of allergic disorders  
such as asthma increased in the several past decades. 
Prevalence of ever asthma in the north of Iran  
and a meta-analysis in Iran were 12% and  
7.6%, respectively.4,5 Some hypotheses for increasing  
of asthma are decreased intake of antioxidant diets  
such as green vegetables and whole grains enriched  
with vitamin E (fat soluble) and increased consumption  
of oxidant’s diet contained free radicals.6  
Exact etiology of asthma is not clear. Genetic  
and environmental factors have role in asthma 
pathogenesis. Nutrition is an important factor  
in induction and exacerbation of asthma. Modern, 
urbanized diets (Increased consumption of processed 
and synthetic foods) and fewer intakes of natural  
and healthy foods such as vegetables and  
fruits may contribute to allergic disorders (i.e. Asthma). 
Researchers are more interested to use antioxidants 
agents such as Vitamins A, C, D, and E to improve 
clinical and pulmonary function in asthmatic patients. 
These agents can decrease or prevent oxidant toxicity 
on respiratory systems.7-9 Some reports showed  
that vitamin E deficiency has been associated  
with decreased pulmonary Function Test (PFT)  
and increased asthma manifestations. Inversely, 
vitamin E supplements both in the form of enriched 
foods or oral preparations improved clinical 
manifestations and PFT in asthmatic patients.2,3 
Vitamin E as a fat-soluble agent has important  
effects on immune system. This agent improves  
T-cell and granulocyte function. Also, vitamin E 
contains Tocoferol and Tocotrinol (each has 4 isomers; 
alpha, beta, gamma and delta) that prevent oxidation  
of metabolic agents such as unsaturated fatty acids.10 
However; there is a serious concern about  
anti-asthmatic synthetic drug especially inhaled 
corticosteroids (ICS). Additive complementary 
medicine such as vitamin E can decrease ICS dose  
and therefore, results in lower side effects.  
Most of human studies conducted in this  
regard were performed on adult population and there 
are a few researches in childhood population  
especially clinical trial studies. The aim of this study 
was to evaluate the effect of vitamin E on PFT  
and clinical manifestations in children with  
moderate asthma. 
 
MATERIAL AND METHODS 
 
This is a randomized double blind placebo-
controlled trial that was performed on children with 
moderate asthma referred to university`s allergic clinic 
at Bouali Hospital in Sari (Iran) from March 2010 to 
March 2012. Sample size included 300 cases (each 
group 150) by following formula based on power 80% 
and accuracy 95%.  
Inclusion criteria were age between 5 to 17 years old, 
moderate asthma for at least 2 years, FEV1 =60-80%.  
Exclusion criteria were abnormal chest x-ray such 
as pneumonia, mass or infiltration except for hyper 
aeration, cardiac disease, acute sinusitis in 3 months 
prior to study, poor cooperation, liver, kidney and other 
systemic disorders; taking a supplemental nutrition 
such as vitamins and mineral trace elements, 
malignancies, gastro esophageal reflux, chest wall 
deformity.  
Diagnosis of asthma was based on clinical 
manifestations, physical examination and PFT. Because 
asthma is a clinical diagnosis, the main course of 
diagnosis of moderate asthma was based on clinical 
manifestations but spirometry was an additional and 
support devices. PFT was done for all the patients 
before and after 8 weeks of treatment (table 3) in 
afternoon between 16 to 18 o’clock. 
The patients were divided into two intervention and 
control groups: the intervention group took moderate-
dose of inhaler steroids (Fluticasone, GSK) and vitamin 
E (50 mg/day) for 8 weeks; the second group received 
moderate inhaler steroid (Fluticasone, GSK) and 
placebo (gelatin, pharmacy faculty, Sari, Iran) for 8 
weeks. vitamin E was used in a dose of 50 mg/day.7  
Serum IgE concentration was determined by 
enzyme linked immunosorbent assay (ELISA) (Mono 
bind, USA) according to manufacturer’s protocol 
(IU/ml). All samples were analyzed in duplicate.  
We evaluated Vitamin E serum level by 
chromatography by HPLC system (model: YL9100 
HPLC, Young Lin Instruments Co. Ltd, Anyang, South 
Korea). Serum normal value of vitamin E was 6-10 
µg/dl. We considered deficiency of vitamin E under 
6µg/dl in children. 
Our data was analyzed by SPSS -13 and student t-
test. P-value less than 0.05 with CI 95% was 
considered significant. This study was approved by the 
local scientific and ethic committees of Mazandaran 
University of Medical Sciences. 
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RESULTS 
 
Three hundred patients were enrolled in this study 
from March 2010 to March 2012 (Figure 1). Out of 240 
cases in this study, 46% (n=110) were female with 
mean age of 8.9±2.14 years (case group=8.4±0.9, 
control group=9.1±1.3); p=0.67 (Table 1). 
Serum level of vitamin E before treatment was 
4.1±1.41 µgr/dl and 4.5±1.8 µgr/dl in case and control 
groups, respectively. Vitamin E level after treatment 
was 8.2±2.4 µgr/dl and 4.7±0.9 µgr/dl in case and 
control groups, respectively (p=0.012) (Table 2). 
Mean serum IgE level was 154.5±33.8 IU/ml and 
118.3±14.4 IU/ml before and after 8 weeks of treatment 
in cases group (p=0.06) but it was 147.2±27.6 IU/ml 
and 127±22.3 IU/ml before and after 8 weeks of 
treatment in control group (p=0.16). 
 
 
 
Figure 1. Patient's selection method from March 2010 to March 2012. 
 
 
Table 1. Demographics characteristics of the case and control groups 
Gender/group Case group (%) Control group (%) P-value Total 
Male  64(53) 66(55) 0.54 130 
Female  56(47) 54(45) 0.52 110 
Total  120(100) 120(100)  240 
Mean age (years)                                        8.4±0.9 9.1±1.3 0.67 8.75±1.1 
 
Table 2. Mean serum level of vitamin E in case and control groups in moderate asthmatic children 
Vitamin E (mean) Cases group Control group 
Before Treatment 4.1±1.41 µgr/dl 4.5±1.8µgr/dl 
After Treatment 8.2±2.4 µgr/dl 4.7±0.9 µgr/dl 
P-value                               0.012 0.068 
 
Table 3. Pulmonary function test in case and control groups in moderate asthmatic children 
PFT Case group 
P-value 
Control group 
P-value 
Before After Before After 
FEV1 71.6±4.1 83.1±5.4 0.001 72.4±3.4 74.8±2.7 0.568 
FVC 95.3±2.4 100.2±1.14 0.432 96.1±1.7 95.8±1.6 0.428 
FEV1/FVC 74.4±2.1 83.2±9.8 0.032 75.1±1.97 5.5±1.8 0.537 
T=treatment; FEV1=forced expiratory volume in 1th time; FVC=forced vital capacity; PFT=pulmonary function test  
Total= 300
Excluded cases:
(60)
25 partial treatment
15 Not returned
15 took other drug
Yes-completed 
(n=240)
Cases= 120
Controls = 120
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Table 4. Coughing, wheezing and exercise induced dyspnea in case and control groups in moderate asthmatic children. 
Symptom Cases group (%) 
P-value 
Control group (%) 
P-value 
Before After Before After 
Cough 83.5 60 0.02 88.4 75.3 0.05 
Wheezing 72.7 55 0.03 75.8 68.7 0.14 
Dyspnea 32.6 20.4 0.04 37.8 31.4 0.24 
            
 
The results of PFT in cases and control groups in 
moderate asthmatic children are shown in Table 3. 
We evaluated clinical manifestations in patients 
before and after 8 weeks of treatment (Table 4). 
 
Statistical Analysis 
We recorded all of our data in spss13. Data were 
expressed as mean ± SD. The comparison between two 
groups was performed with one way analysis of 
variance (ANOVA). Correlation was assessed by 
Pearson correlation (r). P-value of less than 0.05 was 
considered statistically significant. 
 
DISCUSSION 
 
The epithelium lining fluid of lung contains high 
concentration of antioxidants which has protective 
effect against inhaled and endogenous oxidants. The 
main result of this study is that the vitamin E 
supplement has positive effects on both clinical 
manifestations and PFT in children with moderate 
asthma associated with vitamin E deficiency. Similar to 
our study, Romieu et al. found improvement of PFT 
(FEV1, FEF25-75 and PEF) in children with asthma and 
prevention against high levels of Ozoneby using a 
combination of 50mg/day vitamin E and 250mg/day 
Vitamin C.7 Vitamin C could improve function of 
Vitamin E. Contrary to our study, a meta-analysis by 
Gao J et al showed that antioxidant agents such as 
Vitamin C and Vitamin E did not reduce prevalence of 
asthma.8 Pearson in adult asthmatic patients found no 
effect of Vitamin E on clinical manifestations and 
PFT.9 There are some difference in this study including 
the dose of Vitamin E used in mild to moderate asthma.  
It has been shown by Devereux et al that Vitamin E 
can have a primary preventive effect on asthma and 
antenatal vitamin E supplementation was negatively 
associated with asthma ever and current asthma and 
cough at 5 years old. Therefore, low maternal intake of 
vitamin E during pregnancy could increase likelihood 
of asthma in children.10 Contrary to the mentioned 
results, West et al study demonstrated that there was no 
correlation between prenatal diets enriched with β-
carotene, vitamin E or zinc and allergic disorders in 
one-year-old infants, but vitamin C was associated with 
low incidence of allergic diseases.11 Vitamin E 
deficiency can predispose to asthma and there is a 
direct correlation between low levels of Vitamin E and 
inflammatory disorders such as asthma. Similarly, our 
study confirmed the relation between Vitamin E 
deficiencies and induction of the asthma. Also, similar 
results were observed in Scottish cohort study that 
cough and wheezing were reduced in children (at the 
age of 2) when their mothers were supplemented with 
an adequate dose of Vitamin E in pregnancy  due to 
decreased mononuclear proliferative response to 
aeroallergens.12,13 Combinational antioxidant therapy 
(vitamin C with vitamin E or selenium with vitamin E) 
has been shown to be effective in improving of clinical 
symptoms and PFT in asthmatic patients.7 In  
Martindale’s study, Vitamin E and Selenium could  
significantly improve PFT in children with asthma.14 
Selenium is a trace element that improves clinical 
manifestations with anti-inflammatory effects. Vitamin 
E associated with Selenium can act synergistically with 
anti-inflammatory effects in asthmatic patients. 
Some studies showed significant decreases of 
Vitamin E concentration in asthmatics compared to 
non-asthmatic patients.15 Also Al-abdulla showed the 
mean serum level of Vitamin E was significantly lower 
in all asthmatic patients with or without attacks 
compared with non-asthmatic patients. There was 
direct relation between decrease of mean serum level of 
Vitamin E and severity of asthma. 16 
Fogarty et al. found that high intake of Vitamin E 
was associated with lower allergen sensitization and 
decreased serum IgE level. Therefore, vitamin E could 
be a preventive factor of allergic disorders.17 Gilliland 
found that FEF 25-75 (measure of small airways) was 
the only pulmonary function parameter that was 
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decreased significantly after consumption of Vitamin E 
in boys with asthma. They concluded that vitamin E 
could protect small airways. In addition, they found 
decreased in FVC,FEV1 and FEF23-75% with low 
intake of vitamins A,C and E. 18 In our study, FVC, 
FEV1 and FEV1/FVC improved significantly by 
Vitamin E supllementation and this showed the effect 
of Vitamin E on non-small airways.  
  Some studies have shown the lack of association 
between serum concentrations of Vitamin E and 
prevention of asthma. 19,20 
In a study by Schock et al, it was found that 
bronchoalevolar Vitamin E (alpha-Tocopherol) level 
was significantly decreased in atopic patients compared 
to normal individuals.21 
Similar to our study, in other researches conducted 
by Schock et al., pulmonary function levels were lower 
in children with inadequate intake of antioxidant 
vitamins. Alpha-tocopherol was decreased in BAL after 
exercise in mild asthmatic patients but there was no 
significant difference between stable atopic asthma and 
the control group.22 
These differences in serum or BAL concentration of 
vitamin E were related to diet, severity of disease and 
analytical technics employed. Further researches 
showed decrease of antioxidants such as vitamin E in 
asthmatic patients and a direct relationship between 
severity of asthma and decreased serum level of 
vitamin E has been shown.23,24 
 However, irrespective of vitamin E level in lung 
fluid, it seems that increasing serum level of vitamin E 
in improvement of asthma manifestations is important 
and effective.  
 
Allergic disorders such as asthma are sometimes 
associated with increases in total and specific serum 
IgE levels and decreasing serum total or specific IgE 
can improve clinical manifestations of allergic 
diseases.17 In our study, significant decrease in serum 
IgE level was observed after intake of vitamin E 
supplements and this was associated with clinical and 
pulmonary function improvement possibly by T-helper 
cytokine release regulation. 25 
Limitations of this study included short course of 
therapy, inclusion of only persons with moderate 
asthma severity and unknown diet regimes of the study 
group. Also we could not measure the steroid level and 
serum vitamin C levels that might influence vitamin E 
effect. 
In conclusion, we found that in children with 
moderate asthma associated with Vitamin E deficiency, 
50 mg/day Vitamin E supplement has significant effect 
on improving clinical manifestations and PFT. So we 
suggest a study with more sample size with different 
dosages and longer duration of therapy and/or a study 
including different groups of patients with different 
severity of asthma considering their diet and checking 
their steroid levels.  
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